Jennifer C Lai1. 1. University of California, San Francisco, California, USA.
Abstract
PURPOSE OF REVIEW: The most difficult, and perhaps, most important decision that a clinician makes for a patient on the liver transplant wait-list is when 'not' to proceed with liver transplant. Although an individual may be suitable for transplant surgery at listing, he/she may become too sick while waiting. RECENT FINDINGS: This article reviews four specific conditions that commonly arise on the wait-list that may render a candidate too sick for transplant: advancing age, sarcopenia, acute on chronic liver failure, and nonliver-related medical comorbidities. Each condition, per se, is often not a criterion for delisting; the challenge arises when conditions exist in combination--how does one 'sum' up these conditions to quantify risk? Physical frailty, conceptually, represents the conditions in a candidate that are unlikely to reverse after liver function returns, or will take so long to reverse that the patient will be highly vulnerable to postoperative complications. Pretransplant assessments of physical frailty, which are objective, easily administered, and repeated in the clinical setting, enable us to measure the extent to which these factors, in isolation or combination, will reduce both quantity and quality of life after liver transplant. SUMMARY: In this article, I introduce a framework that incorporates objective pretransplant assessments of physical frailty to facilitate the decision regarding when a patient is too sick for transplant.
PURPOSE OF REVIEW: The most difficult, and perhaps, most important decision that a clinician makes for a patient on the liver transplant wait-list is when 'not' to proceed with liver transplant. Although an individual may be suitable for transplant surgery at listing, he/she may become too sick while waiting. RECENT FINDINGS: This article reviews four specific conditions that commonly arise on the wait-list that may render a candidate too sick for transplant: advancing age, sarcopenia, acute on chronic liver failure, and nonliver-related medical comorbidities. Each condition, per se, is often not a criterion for delisting; the challenge arises when conditions exist in combination--how does one 'sum' up these conditions to quantify risk? Physical frailty, conceptually, represents the conditions in a candidate that are unlikely to reverse after liver function returns, or will take so long to reverse that the patient will be highly vulnerable to postoperative complications. Pretransplant assessments of physical frailty, which are objective, easily administered, and repeated in the clinical setting, enable us to measure the extent to which these factors, in isolation or combination, will reduce both quantity and quality of life after liver transplant. SUMMARY: In this article, I introduce a framework that incorporates objective pretransplant assessments of physical frailty to facilitate the decision regarding when a patient is too sick for transplant.
Authors: Michael J Englesbe; Shaun P Patel; Kevin He; Raymond J Lynch; Douglas E Schaubel; Calista Harbaugh; Sven A Holcombe; Stewart C Wang; Dorry L Segev; Christopher J Sonnenday Journal: J Am Coll Surg Date: 2010-06-26 Impact factor: 6.113
Authors: Puneeta Tandon; Michael Ney; Ivana Irwin; Mang M Ma; Leah Gramlich; Vincent G Bain; Nina Esfandiari; Vickie Baracos; Aldo J Montano-Loza; Robert P Myers Journal: Liver Transpl Date: 2012-10 Impact factor: 5.799
Authors: L P Fried; C M Tangen; J Walston; A B Newman; C Hirsch; J Gottdiener; T Seeman; R Tracy; W J Kop; G Burke; M A McBurnie Journal: J Gerontol A Biol Sci Med Sci Date: 2001-03 Impact factor: 6.053
Authors: Elizabeth J Carey; D Eric Steidley; Bashar A Aqel; Thomas J Byrne; Kristin L Mekeel; Jorge Rakela; Hugo E Vargas; David D Douglas Journal: Liver Transpl Date: 2010-12 Impact factor: 5.799
Authors: Jason J Schwartz; Lisa Pappas; Heather F Thiesset; Gabriela Vargas; John B Sorensen; Robin D Kim; William R Hutson; Kenneth Boucher; Terry Box Journal: Liver Transpl Date: 2012-04 Impact factor: 5.799
Authors: Aldo J Montano-Loza; Judith Meza-Junco; Carla M M Prado; Jessica R Lieffers; Vickie E Baracos; Vincent G Bain; Michael B Sawyer Journal: Clin Gastroenterol Hepatol Date: 2011-09-03 Impact factor: 11.382
Authors: A Rana; M A Hardy; K J Halazun; D C Woodland; L E Ratner; B Samstein; J V Guarrera; R S Brown; J C Emond Journal: Am J Transplant Date: 2008-09-25 Impact factor: 8.086
Authors: Mathias Plauth; William Bernal; Srinivasan Dasarathy; Manuela Merli; Lindsay D Plank; Tatjana Schütz; Stephan C Bischoff Journal: Clin Nutr Date: 2019-01-16 Impact factor: 7.324
Authors: Rebecca M Saracino; Devika R Jutagir; Amy Cunningham; Kelly A Foran-Tuller; Mary A Driscoll; William H Sledge; Sukru H Emre; Dwain C Fehon Journal: J Pain Symptom Manage Date: 2018-03-08 Impact factor: 3.612
Authors: Devika R Jutagir; Rebecca M Saracino; Amy Cunningham; Kelly A Foran-Tuller; Mary A Driscoll; William H Sledge; Sukru H Emre; Dwain C Fehon Journal: Palliat Support Care Date: 2018-06-04
Authors: Min Suk Chae; Jong-Woan Kim; Joon-Yong Jung; Ho Joong Choi; Hyun Sik Chung; Chul Soo Park; Jong Ho Choi; Sang Hyun Hong Journal: BMC Anesthesiol Date: 2019-06-28 Impact factor: 2.217